Mats Strömberg

Prognostic significance of proliferative and apoptotic fractions in low grade follicle center cell-derived non-Hodgkin's lymphomas

Magdalena Czader, Joanna Mazur, Mikael Pettersson et al. · Cancer · 1996 · 36 citations · Full text

Late effects of early growth hormone treatment in Down syndrome

Åsa Myrelid, Sven Bergman, Mats Strömberg et al. · Acta Paediatrica · 2010 · 29 citations

Cladribine for Untreated or Early Low-Grade Non-Hodgkin's Lymphoma

Jan Liliemark, Ulla Martinsson, Eva Cavallin Ståhlc et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1998 · 21 citations

Pathology, Pharmacotherapy, Metronomic Chemotherapy +16

Oral cladribine for B‐cell chronic lymphocytic leukaemia: report of a phase II trial with a 3‐d, 3‐weekly schedule in untreated and pretreated patients, and a long‐term follow‐up of 126 previously untreated patients

Karin Karlsson, Mats Strömberg, Jan Liliemark et al. · British Journal of Haematology · 2002 · 18 citations

Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia

Stephen P. Mulligan, Karin Karlsson, Mats Strömberg et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 15 citations

Hematological Malignancy, Lymphoid Neoplasia, Oncology +13